Pharmaceuticals
Teva pressures takeover target Mylan with 1.8% stake buy
03 Jun 2015
Analysts expect Teva to make a sweetened formal bid for Mylan after raising its stake to the 4.6 per cent threshold, because once it tables a formal bid, it cannot buy Mylan shares from the market
Teva settles US antitrust charges for $1.2 bn
29 May 2015
The world’s biggest generic drug maker Israel’s Teva Pharmaceutical Industries has agreed to settle US antitrust charges for illegally blocking competition to its blockbuster sleep-disorder drug Provigil
Diabetes screening will overwhelm India's health system: study
20 May 2015
A large-scale diabetes screening programme underway in India will overwhelm the health system with false positive results, warn researchers
.webp)
